Clinical Trial Update: FQ Restriction for the Prevention of CDI

View source ↗

Summary

The clinical trial update notes that a study evaluating fluoroquinolone restriction to prevent Clostridioides difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Clostridium Difficile, Clostridium Difficile Infection | Status: COMPLETED